HCA
HCA Healthcare, Inc.
HCA Healthcare, Inc. insider trading
HCA Healthcare, Inc. files with the SEC as a Services-General Medical & Surgical Hospitals, NEC company headquartered in Nashville, TN. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
From SEC filings
Recent HCA insider transactions
One insider traded HCA on the open market on Feb 18, 2026 — 1 sale worth $903.5K.
- Bought
- —
- Sold
- $903.5K
- Net
- −$903.5K
- Insiders
- 1
none on a 10b5-1 plan
McAlevey Michael R
EVP & Chief Legal & Admin Off.
−$903.5K
Feb 18, 2026
1,694 sh · $533.37
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Feb 18, 2026 | McAlevey Michael REVP & Chief Legal & Admin Off. | 1,694 | $533.37 | −$903.5K |
SEC Form 4 data, Q3 2024 to Q2 2026
HCA insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 11 insiders traded HCA on the open market: 0 purchases and 26 sales worth $52.8M, 2 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 0 purchases and 14 sales ($32.7M), by 5 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | — | |
| Q1 2026 | — | −$29.3M12 sales | |
| Q4 2025 | — | −$1.8M1 sale | |
| Q3 2025 | — | −$1.6M1 sale · all on a plan | |
| Q2 2025 | — | −$5.8M1 sale | |
| Q1 2025 | — | −$3.1M2 sales | |
| Q4 2024 | — | −$2.9M3 sales | |
| Q3 2024 | — | −$8.3M6 sales · 1 on a plan |
- Largest sale
- −$7.4M of HCA by Hazen Samuel N (CEO · Director) on Feb 03, 2026.
Open-market transactions through Jun 30, 2026most recent first
McAlevey Michael R
EVP & Chief Legal & Admin Off.
−$903.5K
Feb 18, 2026
1,694 sh · $533.37
Berres Jennifer
SVP & Chief Human Res. Officer
−$2.1M
Feb 11, 2026
4,010 sh · $526.16
Wyatt Christopher F.
SVP & Controller
−$2M
Feb 11, 2026
4,000 sh · $505.00
Berres Jennifer
SVP & Chief Human Res. Officer
−$2M
Feb 11, 2026
4,010 sh · $503.00
Hazen Samuel N
CEO · Director
−$7.4M
Feb 03, 2026
14,716 sh · $502.95
Hazen Samuel N
CEO · Director
−$3.7M
Feb 03, 2026
7,395 sh · $500.69
Hazen Samuel N
CEO · Director
−$3.1M
Feb 03, 2026
6,189 sh · $500.02
Hazen Samuel N
CEO · Director
−$2.6M
Feb 03, 2026
5,162 sh · $498.80
Hazen Samuel N
CEO · Director
−$2.5M
Feb 03, 2026
5,002 sh · $502.15
Hazen Samuel N
CEO · Director
−$2.1M
Feb 03, 2026
4,293 sh · $498.12
Cuffe Michael S.
EVP and Chief Clinical Officer
−$747.1K
Feb 03, 2026
1,500 sh · $498.09
Hazen Samuel N
CEO · Director
−$59.7K
Feb 03, 2026
120 sh · $497.18
McAlevey Michael R
EVP & Chief Legal & Admin Off.
−$1.8M
Nov 05, 2025
3,892 sh · $473.79
Cuffe Michael S.10b5-1
EVP and Chief Clinical Officer
−$1.6M
Sep 08, 2025
3,836 sh · $418.84
Foster Jon M
EVP and COO
−$5.8M
May 13, 2025
15,698 sh · $369.32
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Feb 18, 2026 | McAlevey Michael REVP & Chief Legal & Admin Off. | 1,694 | $533.37 | −$903.5K |
| Feb 11, 2026 | Berres JenniferSVP & Chief Human Res. Officer | 4,010 | $526.16 | −$2.1M |
| Feb 11, 2026 | Wyatt Christopher F.SVP & Controller | 4,000 | $505.00 | −$2M |
| Feb 11, 2026 | Berres JenniferSVP & Chief Human Res. Officer | 4,010 | $503.00 | −$2M |
| Feb 03, 2026 | Hazen Samuel NCEO · Director | 14,716 | $502.95 | −$7.4M |
| Feb 03, 2026 | Hazen Samuel NCEO · Director | 7,395 | $500.69 | −$3.7M |
| Feb 03, 2026 | Hazen Samuel NCEO · Director | 6,189 | $500.02 | −$3.1M |
| Feb 03, 2026 | Hazen Samuel NCEO · Director | 5,162 | $498.80 | −$2.6M |
| Feb 03, 2026 | Hazen Samuel NCEO · Director | 5,002 | $502.15 | −$2.5M |
| Feb 03, 2026 | Hazen Samuel NCEO · Director | 4,293 | $498.12 | −$2.1M |
| Feb 03, 2026 | Cuffe Michael S.EVP and Chief Clinical Officer | 1,500 | $498.09 | −$747.1K |
| Feb 03, 2026 | Hazen Samuel NCEO · Director | 120 | $497.18 | −$59.7K |
| Nov 05, 2025 | McAlevey Michael REVP & Chief Legal & Admin Off. | 3,892 | $473.79 | −$1.8M |
| Sep 08, 2025 | Cuffe Michael S.10b5-1EVP and Chief Clinical Officer | 3,836 | $418.84 | −$1.6M |
| May 13, 2025 | Foster Jon MEVP and COO | 15,698 | $369.32 | −$5.8M |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
HCA Healthcare, Inc. company record
- SEC industry classification
- Services-General Medical & Surgical Hospitals, NEC
- Headquarters
- Nashville, TN
- Listed on
- NYSE
- SEC Central Index Key
- 0000860730
- Previously filed as
- HCA Holdings, Inc.
Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.
After insiders bought HCA
What the stock actually did in the 90 days following each open-market purchase
Don't check HCA — let it ping you
Get told the moment an insider moves on HCA
Pro watches HCA Healthcare, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add HCA to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read HCA insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Health Care tickers
Questions
- Are HCA insiders buying or selling?
- Between Feb 18, 2026 and Feb 18, 2026, 1 HCA Healthcare, Inc. insider made no open-market purchases and 1 sale worth $903.5K, a net sale of $903.5K.
- How much HCA stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 11 HCA Healthcare, Inc. insiders made no open-market purchases and 26 sales worth $52.8M. 2 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: no purchases and 14 sales ($32.7M). The largest sale was Hazen Samuel N selling $7.4M on Feb 03, 2026.
- What was the largest recent HCA insider trade?
- McAlevey Michael R (EVP & Chief Legal & Admin Off.) sold $903.5K of HCA stock on Feb 18, 2026 at about $533.37 a share.
- When did an insider last buy HCA shares?
- No open-market purchase by a HCA Healthcare, Inc. insider appears in the filings from Feb 18, 2026 to Feb 18, 2026 — every recorded open-market transaction in that period was a sale.
- Where does HCA insider trading data come from?
- From the Form 4 filings HCA Healthcare, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.